Skip to main content
Clinical Trials/CTRI/2022/06/043124
CTRI/2022/06/043124
Not yet recruiting
Phase 2

A Randomized Open Controlled Clinical Study To Evaluate The Efficacy Of Eladi Kashay In Vatashtheela With Special Reference To Benign Prostatic Hyperplasia

Rutuja Ramesh Gore0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
Sponsor
Rutuja Ramesh Gore
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Rutuja Ramesh Gore

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients with AUA symptom score greater than 8 and less than 19
  • 2\) Rectal Examination consistent with BPH.
  • 3\) Prostate volume greater than 26cc.

Exclusion Criteria

  • 1\) Patients with severe BPH (AUA score greater than 26\)
  • 2\) Patients with Malignancy, HIV, HBsAg, VDRL positive.
  • 3\) Patients suffering from systematic diseases like DM, HTN.
  • 4\) Patients with acute urinary retention.
  • 5\) Obstructive urinary calculi, bladder neck stenosis, cystic calculi.
  • 6\) Patients with pyonephrosis
  • 7\) Patients with acute and chronic renal failure.

Outcomes

Primary Outcomes

Not specified

Similar Trials